Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.263.20 CHF
Change Today -3.80 / -1.42%
Volume 1.6M
ROG On Other Exchanges
Symbol
Exchange
OTC US
OTC US
OTC US
Xetra
SIX Swiss Ex
Xetra
SIX Swiss Ex
Mexico
Frankfurt
As of 11:43 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard H. Scheller Ph.D.

AgeTotal Calculated CompensationThis person is connected to 23 board members in 3 different organizations across 8 different industries.

See Board Relationships
62--

Background*

Dr. Richard H. Scheller, Ph.D., has been the Chief Science Officer and Head of Therapeutics at 23andMe, Inc. since April 2015. Mr. Scheller is responsible for translating genetic information into the discovery and development of new therapies for both common and rare diseases. He serves as a Science Partner at The Column Group LLC. He serves as an Adjunct Professor of the Department of Biochemistry and Biophysics, School of Medicine at University of California, San Francisco. ...

Read Full Background

Corporate Headquarters*

Konzern-Hauptsitz
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

2012-Present
Director
2015-Present
Director

Education*

Bachelor's Degree 1975
University of Wisconsin - Madison
Post-Doctoral Training
Columbia University
Doctorate 1980
California Institute of Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.263.20 CHF -3.80

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.